Fireside Discussion: A Regulatory Perspective on the Complexity of Global Policy & Market Dynamics Towards the Next ADC Approval Beyond TOPO-1

9:30 am - Wednesday 10th March 2027

What are the current regulatory guidelines and regional differences for ADC clinical and commercial pathways?
How as a community can we work with the regulators to reduce impact on development timelines and bring ADCs as standard-of-care therapies?
How are the regulators navigating complex ADC formats from dual-payload, bispecific and novel conjugation strategies?